244
Participants
Start Date
July 31, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Ranibizumab
Injections consisted of 0.5 mg/0.05 ml solution to be injected intravitreally. Ranibizumab was formulated as a sterile solution aseptically filled in a sterile glass vial. It was suitable for single use only and the content of the vial was not allowed to be split
Dexamethasone Implant
Comparator Ozurdex® (dexamethasone) was formulated as a rod shaped implant to be inserted into the eye by an applicator. The implant as well as the respective applicator were suitable for single use only.
Sham injection
Sham injection: Empty sterile syringes were provided so that masking could be maintained. Either empty syringes in the case of sham injections or pre-filled syringes in the case of ranibizumab injections were visible to the patient in the room of study drug administration
Novartis Investigative Site, Budapest
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Kiel
Novartis Investigative Site, Bremen
Novartis Investigative Site, Minden
Novartis Investigative Site, Marburg
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Wolfsburg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Bochum
Novartis Investigative Site, Mülheim
Novartis Investigative Site, Recklinghausen
Novartis Investigative Site, Münster
Novartis Investigative Site, Münster
Novartis Investigative Site, Bad Rothenfelde
Novartis Investigative Site, Cologne
Novartis Investigative Site, Bonn
Novartis Investigative Site, Hagen
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Sulzbach
Novartis Investigative Site, Homburg
Novartis Investigative Site, Ludwigshafen
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, Freiburg I. Br
Novartis Investigative Site, Munich
Novartis Investigative Site, München
Novartis Investigative Site, Ingolstadt
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Ulm
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Prague
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Dresden
Novartis Investigative Site, Glauchau
Novartis Investigative Site, Halle
Novartis Investigative Site, Szeged
Novartis Investigative Site, Bydgoszcz
Novartis Investigative Site, Bytom
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Bradford
Novartis Investigative Site, Cheshire
Novartis Investigative Site, Colchester
Novartis Investigative Site, Derby
Novartis Investigative Site, Gloucester
Novartis Investigative Site, Guildford, Surrey
Novartis Investigative Site, Kent
Novartis Investigative Site, Leeds
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Novartis Investigative Site, Middlesbrough
Novartis Investigative Site, Nottingham
Novartis Investigative Site, Portsmouth
Novartis Investigative Site, Rugby
Novartis Investigative Site, Westcliff-on-Sea
Novartis Investigative Site, York
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY